Search

Edwards Lifesciences Corp

Suletud

SektorTervishoid

85.11 1.31

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

84.32

Max

85.32

Põhinäitajad

By Trading Economics

Sissetulek

-139M

241M

Müük

92M

1.7B

P/E

Sektori keskmine

51.923

47.946

Aktsiakasum

0.78

Kasumimarginaal

13.866

Töötajad

16,000

EBITDA

20M

520M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+22.13% upside

Dividendid

By Acuity

Järgmine tulemuste avaldamine

4. nov 2026

Turustatistika

By TradingEconomics

Turukapital

1.3B

50B

Eelmine avamishind

83.8

Eelmine sulgemishind

85.11

Edwards Lifesciences Corp Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

9. okt 2026, 20:01 UTC

Edwards Lifesciences Corp shares are higher, benefiting from gains in the Health Care Equipment sub-sector, despite a divergence from recent upward trends.

8. okt 2026, 20:01 UTC

Edwards Lifesciences Corp shares are lower, breaking a trend of higher daily closes amid diverging broader market conditions.

7. okt 2026, 20:50 UTC

Edwards Lifesciences Corp declined in after-market trading, continuing a trend of three consecutive sessions lower and remaining below its 20-day moving average.

6. okt 2026, 19:15 UTC

Edwards Lifesciences Corp shares are declining, following unusual volatility, and have fallen to their lowest point of the day amid a cumulative loss since Monday.

5. okt 2026, 20:02 UTC

Social Media
News

Edwards Lifesciences plans an investor event on November 2, 2026, and is on Citi's 90-Day Upside Catalyst Watch List, contributing to its higher trading today.

2. okt 2026, 20:07 UTC

News

Edwards Lifesciences shares fell despite FDA approval of the AUTUS Size-Adjustable Valve for pediatric patients, designed to reduce the need for multiple surgeries.

1. okt 2026, 20:02 UTC

Edwards Lifesciences Corp shares fell sharply, pulling back from an early gain and trading below the 20-day moving average, nearing the lower end of its one-month range.

30. sept 2026, 20:07 UTC

Edwards Lifesciences Corp shares fell sharply, continuing a downward trend and remaining below their 20-day moving average despite a brief recovery earlier in the session.

29. sept 2026, 22:01 UTC

Edwards Lifesciences Corp is trading modestly lower in after-market hours, with its cumulative return showing more pronounced losses following four consecutive higher sessions.

28. sept 2026, 21:21 UTC

Edwards Lifesciences Corp traded modestly lower during after-market hours, remaining 1.39% below its 20-day moving average.

23. sept 2026, 20:02 UTC

Edwards Lifesciences Corp shares fell sharply, remaining well below their 20-day moving average and near the lower end of their one-month range.

22. sept 2026, 23:01 UTC

Edwards Lifesciences Corp is trading modestly higher in after-market hours, nearing the upper end of its one-month trading range.

17. sept 2026, 20:07 UTC

Edwards Lifesciences Corp shares fell sharply on Thursday, continuing a downward trend that began after Wednesday's close, despite peaking in the morning.

16. sept 2026, 23:41 UTC

Edwards Lifesciences Corp saw a modest decline in after-hours trading, continuing a downward trend that has intensified since Wednesday's close.

15. sept 2026, 20:51 UTC

Edwards Lifesciences shares are lower in after-market trading. Broader market sentiment is pressured by rising crude oil prices amid geopolitical tensions in the Middle East.

14. sept 2026, 20:08 UTC

Edwards Lifesciences Corp shares are higher during Monday's session, reflecting an upward trend since Friday's close, despite being below the 20-day moving average.

11. sept 2026, 20:02 UTC

News

Edwards Lifesciences shares are lower despite receiving an Overweight rating and a $101 price target from Piper Sandler amid mixed TAVR coverage sentiment.

8. sept 2026, 20:02 UTC

Correlated Moves

Edwards Lifesciences Corp is declining in Tuesday's session, mirroring broader losses in the medical devices sector and trading below its 20-day moving average.

2. sept 2026, 19:16 UTC

Shares of Edwards Lifesciences Corp. are lower today amid broader market pressures from rising bond yields, reflecting a routine trading pattern.

31. aug 2026, 19:56 UTC

News

Edwards Lifesciences Corp shares are higher today, continuing momentum from Friday. The broader health care equipment sector is also showing strength.

26. aug 2026, 19:56 UTC

Edwards Lifesciences is trading higher, despite a slight pullback from earlier session highs. The stock remains above its 20-day moving average.

24. aug 2026, 19:16 UTC

Edwards Lifesciences Corp shares are higher, continuing positive momentum since Friday's close, despite pulling back from an earlier session high.

20. aug 2026, 20:01 UTC

Edwards Lifesciences Corp shares are lower, driven by a decline in the Health Care Equipment sub-sector and ongoing market weakness since Wednesday's close.

19. aug 2026, 19:26 UTC

Edwards Lifesciences Corp shares are higher during Wednesday's trading session, showing notable volatility while remaining above their 20-day moving average.

18. aug 2026, 23:06 UTC

Edwards Lifesciences shares are lower in after-market hours amid rising U.S. bond yields, contributing to market concerns despite recent softer economic data.

13. aug 2026, 20:06 UTC

Edwards Lifesciences shares are lower today, tracking a broader market decline. The stock remains above its 20-day moving average and near its one-month range.

12. aug 2026, 22:16 UTC

Edwards Lifesciences shares declined in after-market trading, despite earlier fluctuations. The stock remains above its 20-day moving average and near its one-month range.

11. aug 2026, 19:21 UTC

Edwards Lifesciences Corp is trading higher, maintaining upward momentum after four consecutive daily gains and peaking in the late morning session.

10. aug 2026, 19:51 UTC

Edwards Lifesciences shares are higher today, reflecting unusual strength above the 20-day moving average amid uncertainty over the Federal Reserve's interest rate policy.

7. aug 2026, 19:16 UTC

Edwards Lifesciences Corp. shares are higher today, fluctuating within a routine range since Thursday's close, currently trading above its 20-day moving average.

Võrdlus sarnastega

Hinnamuutus

Edwards Lifesciences Corp Prognoos

Hinnasiht

By TipRanks

22.13% tõus

12 kuu keskmine prognoos

Keskmine 104.067 USD  22.13%

Kõrge 110 USD

Madal 85 USD

Põhineb 17 Wall Streeti analüütiku instrumendi Edwards Lifesciences Corp 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

17 ratings

14

Osta

3

Hoia

0

Müü

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Edwards Lifesciences Corp

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.